Skip to content

Popliteal Sciatic Nerve Block: Intraneural or Extraneural?

Blocco Del Nervo Sciatico al Poplite, Intraneurale o Extraneurale? Confronto Prospettico, Randomizzato in Cieco Tra la modalità di Iniezione di Anestetico Locale Per il Blocco Eco Guidato Del Nervo Sciatico al Poplite Nella Chirurgia Dell'Alluce Valgo

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01987128
Enrollment
88
Registered
2013-11-19
Start date
2013-11-30
Completion date
2015-02-28
Last updated
2015-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Brief summary

Aim of this study is to demonstrate the advantages of intraneural injection over extraneural injection in terms of onset and duration on peripheral block. In addition we will evaluate the frequency of possible adverse effects.

Interventions

PROCEDUREIntraneural injection

BBraun Ropivacaine 1% 12ml injection divided in each sciatic components under echographic guidance with a PAJUNK SonoPlex 22G needle.

PROCEDUREExtraneural injection

BBraun Ropivacaine 1% 12ml extraneural injection around sciatic nerve under echographic guidance with a PAJUNK SonoPlex 22G needle.

DRUGRopivacaine
DEVICEPAJUNK SonoPlex 22G needle.

Sponsors

ASST Gaetano Pini-CTO
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA I-II

Exclusion criteria

* Neurological diseases * Diabetes * Allergies to used drugs * Chronic pain in treatment * Electrophysiological alterations at time zero analysis

Design outcomes

Primary

MeasureTime frameDescription
onset timeevery 2 minutes for a maximum of 30 minutesPinprick test evaluation on sciatic nerve territory: With a 22G needle the blinded operator will assess sensitiveness to puncture and then assign a score every 2 minutes for 30 minutes. A score of 0 will describe no sensation to puncture, on the other hand a score of 1 will be assigned if sensation to puncture is still present. Evaluation of motor blockade: Plantar and dorsal flexion of the foot will be evaluated for motor blockade of sciatic nerve. A score of 1 will be assigned if foot movement is conserved, 2 if is impaired and 3 when disappears. Onset time is described as the time at which pinprick score turns to 0 and motor blockade score turns to 3.

Secondary

MeasureTime frameDescription
success rate in each groupat 30 minutesSuccess rate is described as the percentage of subjects with an onset time within 30 minutes in a group among all subjects treated in that group
Nerve injuries1, 5 weeks and at 6 months after surgeryNeurophysiological and clinic evaluation will be assessed either with clinical examination and electrophysiological tests by a neurophysiologist eventually evidencing any movement impairment or dysesthesia in the sciatic territory.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026